US9187527B2ExpiredUtilityA1

Beta sheet tapes ribbons in tissue engineering

90
Assignee: UNIV LEEDSPriority: Jul 15, 2002Filed: Mar 3, 2014Granted: Nov 17, 2015
Est. expiryJul 15, 2022(expired)· nominal 20-yr term from priority
A61K 8/64A61L 2430/32A61L 27/227A61L 27/22A61L 2430/02C09K 8/62A61P 43/00A61Q 11/00A61L 2430/34A61L 31/14A61Q 19/00A61L 31/047C09K 2208/08A61L 27/52C07K 7/06A61K 47/42A61L 27/38A61L 2400/18A61L 27/56A61L 2430/12A61Q 5/00A61L 27/60
90
PatentIndex Score
5
Cited by
27
References
20
Claims

Abstract

There is described a material comprising tapes, ribbons, fibrils or fibers characterized in that each of the ribbons, fibrils or fibers have an antiparallel arrangement of peptides in a β-sheet tape-like substructure.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method of treating and/or alleviating dental caries, comprising:
 contacting a composition comprising a peptide P11-4 (SEQ ID NO: 1) to an affected tooth surface, thereby treating the caries. 
 
     
     
       2. The method of  claim 1 , wherein the peptide P11-4 (SEQ ID NO: 1) forms or is present as a gel at a physiological pH. 
     
     
       3. The method of  claim 1 , wherein the peptide P11-4 (SEQ ID NO: 1) forms or is present as ribbons, fibrils or fibres at a physiological pH. 
     
     
       4. The method of  claim 1 , wherein the peptide P11-4 (SEQ ID NO: 1) is conjugated to a bioactive peptide. 
     
     
       5. The method according to  claim 1 , wherein the peptide P11-4 (SEQ ID NO: 1) is conjugated to a therapeutically active molecule. 
     
     
       6. A method of promoting mineralisation or remineralisation of dental tissue, comprising:
 contacting a composition comprising a peptide P11-4 (SEQ ID NO: 1) to a dental tissue to be treated, thereby promoting mineralisation or remineralisation of the dental tissue. 
 
     
     
       7. The method of  claim 6 , wherein the peptide P11-4 (SEQ ID NO: 1) forms or is present as a gel at a physiological pH. 
     
     
       8. The method of  claim 6 , wherein the peptide P11-4 (SEQ ID NO: 1) forms or is present as ribbons, fibrils or fibres at a physiological pH. 
     
     
       9. The method of  claim 6 , wherein the peptide P11-4 (SEQ ID NO: 1) is conjugated to a bioactive peptide. 
     
     
       10. The method of  claim 6 , wherein the peptide P11-4 (SEQ ID NO: 1) is conjugated to a therapeutically active molecule. 
     
     
       11. A method of decreasing or suppressing demineralisation of dental tissue, comprising:
 contacting a composition comprising a peptide P11-4 (SEQ ID NO: 1) to a dental tissue. to be treated, thereby decreasing or suppressing demineralisation of the dental tissue. 
 
     
     
       12. The method of  claim 11 , wherein the peptide P11-4 (SEQ ID NO: 1) forms or is present as a gel at a physiological pH. 
     
     
       13. The method of  claim 11 , wherein the peptide P11-4 (SEQ ID NO: 1) forms or is present as ribbons, fibrils or fibres at a physiological pH. 
     
     
       14. The method of  claim 11 , wherein the peptide P11-4 (SEQ ID NO: 1) is conjugated to a bioactive peptide. 
     
     
       15. The method of  claim 11 , wherein the peptide P11-4 (SEQ ID NO: 1) is conjugated to a therapeutically active molecule. 
     
     
       16. A method of treating and/or alleviating dental hypersensitivity, comprising:
 contacting a composition comprising a peptide P11-4 (SEQ ID NO: 1) to a dental tissue to be treated, thereby treating and/or alleviating dental hypersensitivity of the dental tissue. 
 
     
     
       17. The method of  claim 16 , wherein the peptide P11-4 (SEQ ID NO: 1) forms a gel or is present as a gel at a physiological pH. 
     
     
       18. The method of  claim 16 , wherein the peptide P11-4 (SEQ ID NO: 1) forms or is present as ribbons, fibrils or fibres at a physiological pH. 
     
     
       19. The method of  claim 16 , wherein the peptide P11-4 (SEQ ID NO: 1) is conjugated to a bioactive peptide. 
     
     
       20. The method of  claim 16 , wherein the peptide P11-4 (SEQ ID NO: 1) is conjugated to a therapeutically active molecule.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.